Homepage - Take on Typhoid

Is the introduction of typhoid conjugate vaccines (TCVs) a cost-effective solution for your country?

Check out our new TCV cost-effectiveness modeling tool

here!
Typhoid conjugate vaccine found to be over 81% efficacious in tackling disease in Nepal

Read the full analysis of TyVAC’s Phase 3 efficacy study in Nepal in The New England Journal of Medicine.

Read More
Pakistan introduces typhoid conjugate vaccine

On November 15, Pakistan became the first country in the world to introduce the World Health Organization-recommended typhoid conjugate vaccine into its routine immunization program.

Learn More
Country Tools

New country-specific tools outline the burden of typhoid and the potential benefits of new typhoid conjugate vaccines in each country.

Read More

Typbar-TCV® Prequalification: Questions and Answers

The first typhoid conjugate vaccine has been prequalified by the World Health Organization. Learn what this means for typhoid prevention and control around the world, and how this can help us take on typhoid.

Talk about Typhoid

Communicate the impact of typhoid on the health and development of children and families around the world and the value of an integrated package of solutions for typhoid control and prevention with our menu of messages.

Newsletter Signup

Name

Affiliation

Country

By clicking subscribe, I acknowledge that I have read and consented to Take on Typhoid’s privacy policy.

Is the introduction of typhoid conjugate vaccines (TCVs) a cost-effective solution for your country?

Typhoid conjugate vaccine found to be over 81% efficacious in tackling disease in Nepal

Pakistan introduces typhoid conjugate vaccine

Country Tools

Our Blog

Stories of Typhoid: Gift King’Oo

Experts gather to take action on typhoid and cholera

The long bumpy road to typhoid conjugate vaccine introduction

Policy & Advocacy

Typbar-TCV® Prequalification: Questions and Answers

Talk about Typhoid

Nearly 11 million

More than 116,000

Typhoid can be prevented